A clinical-laboratory algorithm incorporating optical density value to predict heparin-induced thrombocytopenia

Thrombosis and Haemostasis

Volumn 105, Issue 3, 2011, Pages 553-559

  Ruf, Kathryn M ^a   Bensadoun, Eric S ^a   Davis, George A ^a   Flynn, Jeremy D ^a   Lewis, Daniel A ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

4T score; Direct thrombin inhibitor; Heparin induced thrombocytopenia; Optical density; Serotonin release assay

Indexed keywords

THROMBIN INHIBITOR;

ADULT; AGED; ALGORITHM; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTICAL DENSITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROTONIN RELEASE;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; FALSE POSITIVE REACTIONS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PROBABILITY; RETROSPECTIVE STUDIES; THROMBIN; THROMBOCYTOPENIA; THROMBOSIS;

EID: 79952502409     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-09-0610     Document Type: Article

References (23)

1. Warkentin TE, Greinacher A, Koster A, et al. Treatment and prevention of heparin- induced thrombocytopenia: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 340S-380S.
2. Napolitano LM, Warkentin TE, Almahameed A, et al. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Crit Care Med 2006; 34: 2898-2911. (Pubitemid 44808730)
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost1998; 79: 1-7.
4. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121: 535-555. (Pubitemid 36645375)
5. Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia. Arch Pathol Lab Med 2002; 126: 1415-1423.
6. Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759-765.
7. Denys B, Stove V, Philippe J, et al. A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia. Thromb Res 2008; 123: 137-145.
8. Wirth SM, Macaulay TE, Armitstead JA, et al. Evaluation of a Clinical Scoring Scale to Direct Early Appropriate Therapy in Heparin-Induced Thrombocytopenia. J Oncol Pharm Pract 2010; 16: 161-166.
9. Warkentin TE, Hayward CP, Smith CA, et al. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med 1992; 120: 371-379.
10. Dager WE, Dougherty JA, Nguyen PH, et al. Heparin-induced thrombocytopenia: treatment options and special considerations. Pharmacotherapy 2007; 27: 564-587. (Pubitemid 46536238)
11. Trossaert M, Gaillard A, Commin PL, et al. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol 1998; 101: 653-655. (Pubitemid 28308512)
12. Francis JL, Palmer GJ, 3rd, Moroose R, Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg 2003; 75: 17-22. (Pubitemid 36099015)
13. Zwicker JI, Uhl L, Huang WY, et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004; 2: 2133-2137. (Pubitemid 40185772)
14. Altuntas F, Matevosyan K, Burner J, et al. Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia. Eur J Haematol 2008; 80: 429-435. (Pubitemid 351503102)
15. Untch B, Ahmad S, Jeske WP, et al. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG. Thromb Res 2002; 105: 117-123. (Pubitemid 34214926)
16. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 311S-337S.
17. Lewis BE, Wallis DE, Hursting MJ, et al. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Chest 2006; 129: 1407-1416. (Pubitemid 43894967)
18. Lewis BE, Wallis DE, Berkowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001; 103: 1838-1843. (Pubitemid 32328395)
19. Kiser TH, Burch JC, Klem PM, et al. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia. Pharmacotherapy 2008; 28: 1115-1124.
20. Janatpour KA, Gosselin RC, Dager WE, et al. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia. Am J Clin Pathol 2007; 127: 429-433. (Pubitemid 46806337)
21. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2008; 100: 678-684.
22. Pouplard C, Leroux, D, Regina S, et al. Effectiveness of ne immuno-assay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies. Thromb Haemost 2010; 103: 145-150.
23. Legnani C, Cini M, Pili C, et al. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin- induced thrombocytopenia. Thromb Haemost 2010; 104: 402-409.